Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lothar Bergmann

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 7, 2009
Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cellsWolfgang Glienke, Luise Maute, Johannes Wicht, et al.
Leukemia & Lymphoma|September 13, 2006
Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compoundsWolfgang Glienke, Kai U Chow, Nina Bauer, et al.
Aktuelle Urologie|April 14, 2017
[Interdisciplinary Recommendations for the Treatment of Metastatic Renal Cell Carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2008
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in GermanyHolger Gerullis, Lothar Bergmann, Luise Maute, et al.
Leukemia & Lymphoma|September 14, 2004
Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)Gerd Munzert, Dieter Kirchner, Oliver Ottmann, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Positron emission tomography (PET) for staging of solitary plasmacytomaHolger Schirrmeister, Andreas K Buck, Lothar Bergmann, et al.
Aktuelle Urologie|September 6, 2019
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Experimental Hematology|June 28, 2003
Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activationDieter Kirchner, Justus Duyster, Oliver Ottmann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2011
The preclinical and clinical activity of aviscumine: a potential anticancer drugHeinz Zwierzina, Lothar Bergmann, Heiner Fiebig, et al.
Blood|November 2, 2002
Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosisGerd Munzert, Dieter Kirchner, Heike Stobbe, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|February 7, 2009
Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cellsWolfgang Glienke, Luise Maute, Johannes Wicht, et al.
Leukemia & Lymphoma|September 13, 2006
Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compoundsWolfgang Glienke, Kai U Chow, Nina Bauer, et al.
Aktuelle Urologie|April 14, 2017
[Interdisciplinary Recommendations for the Treatment of Metastatic Renal Cell Carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2008
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in GermanyHolger Gerullis, Lothar Bergmann, Luise Maute, et al.
Leukemia & Lymphoma|September 14, 2004
Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)Gerd Munzert, Dieter Kirchner, Oliver Ottmann, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Positron emission tomography (PET) for staging of solitary plasmacytomaHolger Schirrmeister, Andreas K Buck, Lothar Bergmann, et al.
Aktuelle Urologie|September 6, 2019
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Experimental Hematology|June 28, 2003
Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activationDieter Kirchner, Justus Duyster, Oliver Ottmann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2011
The preclinical and clinical activity of aviscumine: a potential anticancer drugHeinz Zwierzina, Lothar Bergmann, Heiner Fiebig, et al.
Blood|November 2, 2002
Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosisGerd Munzert, Dieter Kirchner, Heike Stobbe, et al.
Pageof 5